Balyasny Asset Management LLC Instil Bio, Inc. Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$0.51 - $0.67 $8,396 - $11,030
16,463 New
16,463 $9,000
Q4 2021

Feb 14, 2022
SELL
$15.37 - $22.5 $405,568 - $593,707
-26,387 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$15.05 - $23.28 $397,124 - $614,289
26,387 New
26,387 $472,000

Others Institutions Holding TIL

# of Institutions
2
Shares Held
1.9M
Call Options Held
0
Put Options Held
0
View Full List

About Instil Bio, Inc.

TIL Quotes by TradingView
  • Ticker TIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,694,000
  • Market Cap $2.82B
  • Description
  • Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...
More about TIL
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email